Masao Suzuki, L.Ac., Ph.D., of Kyoto Meiji and University University of Integrative Medicine, Kyoto, Japan, and co-workers conducted a randomized controlled trial from July 2006 through March 2009. A total of 68 patients diagnosed with COPD participated, and 34 were designated to a genuine acupuncture group for 12 weeks, plus daily medication. The additional 34 were designated to a placebo acupuncture group where the needles had been blunt . The primary measure was the evaluation of a six-minute walk check on a Borg scale where 0 meant inhaling and exhaling very well, barely breathless and 10 signified severely breathless.To see the Multimedia News Release, please click: In the Actions to regulate Cardiovascular Risk in Diabetes Lipid trial, published on-line in the brand new England Journal of Medicine, the group with atherogenic dyslipidemia had 70 % more cardiovascular events than sufferers without. Actually, the risk connected with atherogenic dyslipidemia was much like that in people with previous coronary disease . Professor Jean-Charles Fruchart, President of the rest of the Risk Reduction Initiative , an independent Swiss academic foundation, said: ‘For the last two years, the R3i has centered on the hypothesis that residual cardiovascular risk in statin-treated patients is connected with atherogenic dyslipidemia.